Burden and determinants of hyperglycaemia and dyslipidaemia in Zimbabwean adults living with HIV on dolutegravir-based first-line antiretroviral therapy: A cross-sectional study
Ratidzo Chirimo, Danai Tavonga Zhou, Tinashe Mudzviti, Ian Machingura Ruredzo, Justen Manasa, Charles Chiedza Maponga, Zvenyika Alfred Reginald Gomo, Exnevia Gomo · 2026
Read Burden and determinants of hyperglycaemia and dyslipidaemia in Zimbabwean adults living with HIV on dolutegravir-based first-line antiretroviral therapy: A cross-sectional study by Ratidzo Chirimo, Danai Tavonga Zhou, Tinashe Mudzviti, Ian Machingura Ruredzo, Justen Manasa, Charles Chiedza Maponga, Zvenyika Alfred Reginald Gomo, Exnevia Gomo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359196.txt.
Description
Ratidzo Chirimo and seven colleagues wrote this 2026 PLOS ONE research article set in Zimbabwe. It studies adults living with HIV who take first-line antiretroviral therapy built on dolutegravir. The authors measure the burden of two metabolic problems, high blood sugar and abnormal blood fats, and hunt for their determinants.
The study is cross-sectional, taking a snapshot of patients on this widely used HIV treatment. As HIV care succeeds and patients live longer, heart and metabolic risks become the next threat. Clinic teams in Zimbabwe and similar programs can use burden figures like these to add screening for diabetes and cholesterol to routine HIV visits.
Catalog record
| CREATOR | Ratidzo Chirimo, Danai Tavonga Zhou, Tinashe Mudzviti, Ian Machingura Ruredzo, Justen Manasa, Charles Chiedza Maponga, Zvenyika Alfred Reginald Gomo, Exnevia Gomo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36293 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |